Nomura Holdings’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-16,665
Closed -$1.64M – 1914
2025
Q3
$1.64M Buy
16,665
+8,982
+117% +$960K ﹤0.01% 1221
2025
Q2
$818K Sell
7,683
-23,338
-75% -$2.36M ﹤0.01% 1043
2025
Q1
$2.82M Buy
+31,021
New +$3.47M 0.01% 916
2024
Q3
– Sell
-4,200
Closed -$338K – 1565
2024
Q2
$338K Buy
+4,200
New +$384K ﹤0.01% 1425
2022
Q3
– Sell
-8,772
Closed -$1.25M – 1701
2022
Q2
$1.25M Buy
8,772
+2,495
+40% +$381K ﹤0.01% 900
2022
Q1
$1.1M Buy
6,277
+2,046
+48% +$344K ﹤0.01% 1073
2021
Q4
$1.09M Sell
4,231
-1,054
-20% -$289K ﹤0.01% 1186
2021
Q3
$1.47M Buy
+5,285
New +$1.68M ﹤0.01% 1012
2020
Q4
– Sell
-5,800
Closed -$401K – 1523
2020
Q3
$401K Buy
+5,800
New +$416K ﹤0.01% 1051

Other funds holding BNTX

Nomura Holdings's BNTX Position: Q4 2025 in Review

Nomura Holdings sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 16,665 shares — an estimated $1.64M sold.

Nomura Holdings first reported a position in BNTX in Q3 2020 and held it in 9 quarters. The position peaked at $2.82M in Q1 2025. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Nomura Holdings reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Nomura Holdings sold 16,665 BioNTech shares in Q4 2025, an estimated $1.64M.
  • Nomura Holdings first reported a position in BioNTech in Q3 2020 and held it in 9 quarters.
  • Nomura Holdings's BioNTech position peaked at $2.82M in Q1 2025.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Nomura Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.